News from IrsiCaixa

All the news in a click

RBDCOV initiates the first Phase III clinical trial of HIPRA's COVID-19 vaccine in immunocompromised people

Some antigen tests are 10 times less sensitive against certain SARS-CoV-2 variants, but effective with omicron

Improving the mental health promotion model in schools: a priority challenge for the education community

People with low HIV reservoir and located in short-lived cells, an ideal scenario for eradicating the virus

Light-based device uses a few drops of saliva to effectively test COVID-19 patients

Key to plitidepsin's success, preventing SARS-CoV-2 replication inside cells

The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients

Study shows efficacy of remdesivir in preventing severity of COVID-19 and European Commission extends its use in people at risk

Promoted by:

'La Caixa' Foundation

Member of:

In cooperation with: